Erste Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$713K Hold
15,000
0.01% 572
2025
Q1
$598K Hold
15,000
0.01% 418
2024
Q4
$831K Hold
15,000
0.01% 405
2024
Q3
$741K Hold
15,000
0.01% 403
2024
Q2
$625K Hold
15,000
0.01% 404
2024
Q1
$753K Buy
+15,000
New +$753K 0.01% 393